Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Axogen Inc

AXGN
Current price
7.15 USD +0.31 USD (+4.53%)
Last closed 6.88 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 296 139 968 USD
Yield for 12 month -34.58 %
Week
Month
Year
AXGN
21.11.2021 - 28.11.2021

AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida. Address: 13631 Progress Boulevard, Alachua, FL, United States, 32615

Analytics

WallStreet Target Price

11.5 USD

P/E ratio

Dividend Yield

2.61 %

Current Year

+138 584 000 USD

Last Year

+127 358 000 USD

Current Quarter

+41 271 000 USD

Last Quarter

+38 155 000 USD

Current Year

+114 437 000 USD

Last Year

+104 427 000 USD

Current Quarter

+33 228 000 USD

Last Quarter

+30 927 000 USD

Key Figures AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -20 290 000 USD
Operating Margin TTM -9.75 %
PE Ratio
Return On Assets TTM -7.65 %
PEG Ratio
Return On Equity TTM -23.33 %
Wall Street Target Price 11.5 USD
Revenue TTM 152 254 000 USD
Book Value 2.27 USD
Revenue Per Share TTM 3.57 USD
Dividend Share
Quarterly Revenue Growth YOY 11.7 %
Dividend Yield 2.61 %
Gross Profit TTM 114 437 000 USD
Earnings Share -0.55 USD
Diluted Eps TTM -0.55 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -15.26 %

Dividend Analytics AXGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 27.01.2010
Forward Annual Dividend Yield 2.61 %
Last Split Factor 105:100
Payout Ratio
Last Split Date 11.07.1994
Dividend Date 12.02.2010

Stock Valuation AXGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.1779
Price Sales TTM 1.945
Enterprise Value EBITDA -19.0399
Price Book MRQ 3.0343

Financials AXGN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators AXGN

For 52 weeks

3.45 USD 11.32 USD
50 Day MA 4.85 USD
Shares Short Prior Month 1 618 907
200 Day MA 7.45 USD
Short Ratio 3.6
Shares Short 2 156 465
Short Percent 5.39 %